I have heard back from Stemedica on some questions I had on their role in the stem cell intervention done on hockey legend Gordie Howe. I heard from Marcie J. Frank, VP at Stemedica for Investor Relations. I want to thank her for answering the questions and doing so so quickly. Q: Did Stemedica write the […]
Response from Stemedica on Stem Cell Treatment of Howe Read More »
One of the bigger stem cell stories in the past week was that hockey legend Gordie Howe had received a stem cell ‘treatment” that had “miraculous” positive effects after having a few strokes over the last couple months. (update: see more on celebrities rolling the dice on unproven stem cells here). I am highly skeptical of
Checking Supposed Stem Cell Miracle for Gordie Howe Read More »
With a new document released today the FDA is more clearly on a path to regulate dubious stem cell clinics in the US. Update: in the years since this post, the FDA has more concretely defined autologous adipose stem cells as drug products. There are more than 100 such American clinics that are selling stem
FDA Draft Guidance Views Fat Stem Cells As Drugs Read More »
Brigham and Women’s Hospital cardiac stem cell researcher Piero Anversa along with collaborator Annarosa Leri (pictured) are suing both the hospital and Harvard Medical School as well as leaders at the institutions over a research misconduct investigation focused on Anversa and Leri. Boston Globe reporter Carolyn Johnson has been covering Anversa and for background on this new
Harvard Sued by Anversa Over Stem Cell Paper Misconduct Investigation Read More »
For the worlds of biology and cell biology including the stem cell field more specifically, the holidays came early with some fantastic news. Philanthropist and Microsoft co-Founder Paul Allen will give $100 million to form a new institute focused on cell biology in Seattle. The Allen Institute for Cell Science has an ambitious mission dedicated to
Founding of The Allen Institute for Cell Science Read More »
How cool is it that literally fuzzy new stem cells called “F-class cells” bring substantial new sharp focus to the cellular reprograming arena? Remember Project Grandiose led by the great stem cell scientist Andras Nagy? It’s a massive project intended to decipher what makes stem cells tick and how ordinary cells be changed or reprogrammed into powerful
Fuzzy New Stem Cells Bring Cellular Reprogramming into Focus Read More »
NBC News did a big on-line story and even a NBC Nightly News Segment on dubious stem cell therapies on Friday. Normally a national news story on the problem of the mushrooming stem cell clinics selling unapproved “treatments” would be a positive development, but this otherwise very nicely done story might have a major error that could confuse millions
Did NBC News Err On Key Part of Their Stem Cell Report? Read More »
The Niche is the top, most authoritative stem cell and regenerative medicine blog on the web. It’s the only one to our knowledge written mostly by a professor. Professor Paul Knoepfler of UC Davis School of Medicine, an internationally respected stem cell biologist and educator, runs The Niche. Knoepfler is an advocate of rigorous evidence-based
About Us, The Niche and Knoepfler Lab Read More »
It’s been a seemingly rather quiet year on the FDA regulatory front in the US when it comes to direct-to-consumer stem cell interventions even as the number of dubious stem cell clinics continues to skyrocket. I requested an interview with the FDA to cover the key pressing issues in this arena. I want to thank
FDA on Key Stem Cell Regulatory Issues & Its Own Research Read More »
The following is a response to my Open Letter to the UK Parliament on mitochondrial transfer/3-parent technology from Drs. Peter Braude and Robin Lovell-Badge. Dear Professor Knoepfler, We read your open letter to the UK Parliament and the Science and Technology Committee with interest and concern. We are two scientists, like you, with particular interests